Frontal affinity chromatography in characterizing immobilized receptors

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 5, 2011, Pages 911-925

  Calleri, E ^a   Temporini, C ^a   Massolini, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Binding affinity; Biochromatography; Frontal affinity chromatography (FAC); On line screening; Receptor immobilization

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BUNGAROTOXIN RECEPTOR; CALCIUM CHANNEL L TYPE; CELL NUCLEUS RECEPTOR; CYTOSOL RECEPTOR; EPHRIN RECEPTOR B2; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; HISTAMINE H1 RECEPTOR; IMMOBILIZED RECEPTOR; ION CHANNEL; KAPPA OPIATE RECEPTOR; LIGAND; MEMBRANE RECEPTOR; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; PURINERGIC P2Y1 RECEPTOR; RECEPTOR; SILICON DIOXIDE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; BINDING SITE; CELL MEMBRANE; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG TARGETING; FRONTAL AFFINITY CHROMATOGRAPHY; HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; LIGAND BINDING; MASS SPECTROMETRY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; REVIEW; TORPEDO CALIFORNICA;

ANIMALS; BINDING SITES; CHROMATOGRAPHY, AFFINITY; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMOBILIZED PROTEINS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 78751703225     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.11.040     Document Type: Review

References (58)

1. Mayr L.M., Bojanic D. Novel trends in high-throughput screening. Curr. Opin. Pharmacol. 2009, 9:580-588.
2. Gribbon P., Sewing A. High-throughput drug discovery: what can we expect from HTS?. Drug Discov. Today 2005, 10:17-22.
3. Renaud J.-P., Delsuc M.-A. Biophysical techniques for ligand screening and drug design. Curr. Opin. Pharmacol. 2009, 9:622-628.
4. Keserü G.M., Makara G.M. Hit discovery and hit-to-lead approaches. Drug Discov. Today 2006, 11:741-748.
5. Whitehurst C.E., Annis D.A. Affinity selection-mass spectrometry and its emerging application to the high throughput screening of G protein-coupled receptors. Comb. Chem. High Throughput Screen. 2008, 11:427-438.
6. Geoghegan K.F., Kelly M.A. Biochemical applications of mass spectrometry in pharmaceutical drug discovery. Mass Spectrom. Rev. 2005, 24:347-366.
7. Schiel J.E., Joseph K.S., Hage D.S. Biointeraction affinity chromatography: general principles and recent developments. Adv. Chromatogr. 2010, 48:145-193.
8. Hage D.S. Affinity chromatography: a review of clinical applications. Clin. Chem. 1999, 45:593-615.
9. Hage D.S., Jackson A., Sobansky M.R., Schiel J.E., Yoo M.J., Joseph K.S. Characterization of drug-protein interactions in blood using high-performance affinity chromatography. J. Sep. Sci. 2009, 32:835-853.
10. Schiel J.E., Mallik R., Soman S., Joseph K.S., Hage D.S. Applications of silica supports in affinity chromatography. J. Sep. Sci. 2006, 29:719-737.
11. Kasai K., Ishii S. Quantitative analysis of affinity chromatography of trypsin. A new technique for investigation of protein-ligand interaction. J. Biochem. 1975, 77:261-264.
12. Schriemer D.C., Bundle D.R., Li L., Hindsgaul O. Micro-scale frontal affinity chromatography with mass spectrometry detection: a new method for the screening of compound libraries. Angew. Chem. Int. Ed. 1998, 37:3383-3387.
13. Ng E.S., Schriemer D.C. Emerging challenges in ligand discovery: new opportunities for chromatographic assay. Expert Rev. Proteomics 2005, 2:891-900.
14. Ng E.S., Chan N.W., Lewis D.F., Hindsgaul O., Schriemer D.C. Frontal affinity chromatography-mass spectrometry. Nat. Protoc. 2007, 2:1907-1917.
15. Calleri E., Temporini C., Caccialanza G., Massolini G. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry. ChemMedChem 2009, 4:905-916.
16. Chan N., Lewis D., Kelly M., Ng E.S.M., Schriemer D.C. Mass Spectrometry in Medicinal Chemistry 2007, pp. 217-246 (Chapter 6). K.T. Wanner, G. Höfner (Eds.).
17. Moaddel R., Lu L., Baynham M., Wainer I.W. Immobilized receptor- and transporter-based liquid chromatographic phases for on-line pharmacological and biochemical studies: a mini-review. J. Chromatogr. B 2002, 768:41-53.
18. Winzor D.J. Determination of binding constants by affinity chromatography and enzymes. J. Chromatogr. A 2004, 1037:351-367.
19. Bertucci C., Bartolini M., Gotti R., Andrisano V. Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis. J. Chromatogr. B 2003, 797:111-129.
20. Moaddel R., Wainer I.W. Development of immobilized membrane-based affinity columns for use in the online characterization of membrane bound proteins and for targeted affinity isolations. Anal. Chim. Acta 2006, 564:97-105.
21. Slon-Usakiewicz J.J., Ng W., Foster J.E., Dai J.-R., Deretey E., Toledo-Sherman L., Redden P.R., Pasternak A., Reid N. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA. J. Med. Chem. 2004, 47:5094-5100.
22. Ng W., Dai J.-R., Slon-Usakiewicz J.J., Redden P.R., Pasternak A., Reid N. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS). J. Biomol. Screen. 2007, 12:167-174.
23. Zhu L., Chen L., Luo H., Xu X. Frontal affinity chromatography combined on-line with mass spectrometry: a tool for the binding study of different epidermal growth factor receptor inhibitors. Anal. Chem. 2003, 75:6388-6393.
24. Luo H., Chen L., Li Z., Ding Z., Xu X. Frontal immunoaffinity chromatography with mass spectrometric detection: a method for finding active compounds from traditional Chinese herbs. Anal. Chem. 2003, 75:3994-3998.
25. Kim H.S., Hage D.S. Immobilization methods for affinity chromatography. Handbook of Affinity Chromatography 2005, CRC Press/Taylor & Francis, (chapter 3). D.S. Hage (Ed.).
26. Mallik R., Hage D.S. Affinity monolith chromatography. J. Sep. Sci. 2006, 29:1686-1704.
27. Brekkan E., Lundqvist A., Lundahl P. Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and d-glucose with the human red cell glucose transporter. Biochemistry 1996, 35:12141-12145.
28. Gottschalk I., Lagerquist C., Zuo S.-S., Lundqvist A., Lundahl P. Immobilized-biomembrane affinity chromatography for binding studies of membrane proteins. J. Chromatogr. B 2002, 768:31-40.
29. Pidgeon C., Marcus C., Alvarez F. Applications of Enzyme Biotechnology 1992, Plenum Press, New York. T.O. Baldwin, J.W. Kelly (Eds.).
30. Moaddel R., Wainer I.W. The preparation and development of cellular membrane affinity chromatography columns. Nat. Protoc. 2009, 4:197-205.
31. He L., Wang S., Yang G., Zhang Y., Wang C., Yuan B., Hou X. Progress in cell membrane chromatography. Drug Discov. Ther. 2007, 1:104-107.
32. Yuan B.X., Hou J., Yang G.D., Zhao L.M., He L. Comparison of determination of drug-muscarinic receptor affinity by cell membrane chromatography and by radioligand binding assay with the cerebrum membrane of the rat. Chromatographia 2005, 619:381-384.
33. Yu W., Yuan B., Deng X., He L., Youyi Z., Qide H. The preparation of HEK293 α1A or HEK293 α1B cell membrane stationary phase and the chromatographic affinity study of ligands of α1 adrenoreceptor. Anal. Biochem. 2005, 339:198-205.
34. Wang Y., Yuan B., Deng X., He L., Wang S., Zhang Y., Han Q. Comparison of alpha1-adrenergic receptor cell-membrane stationary phases prepared from expressed cell line and from rabbit hepatocytes. Anal. Bioanal. Chem. 2006, 386:2003-2011.
35. Zeng A., Yuan B., Wang C., Yang G., He L. Frontal analysis of cell-membrane chromatography for the determination of drug-α1D adrenergic receptor affinity. J. Chromatogr. B 2009, 877:1833-1837.
36. Lebert J.M., Forsberg E.M., Brennan J.D. Solid-phase assays for small molecule screening using sol-gel entrapped proteins. Biochem. Cell Biol. 2008, 86:100-110.
37. Landry Y., Gies J.-P. Drugs and their molecular targets: an updated overview. Fundam. Clin. Pharmacol. 2008, 22:F1-F18.
38. Moaddel R., Jozwiak K., Whittington K., Wainer I.W. Conformational mobility of immobilized alpha3beta2, alpha3beta4, alpha4beta2, and alpha4beta4 nicotinic acetylcholine receptors. Anal. Chem. 2005, 77:895-901.
39. Zhang Y., Xiao Y., Kellar K.J., Wainer I.W. Immobilized nicotinic receptor stationary phase for on-line liquid chromatographic determination of drug-receptor affinitie. Anal. Biochem. 1998, 264:22-25.
40. WainerF I.W., Zhang Y., Xiao Y., Kellar K.J. Liquid chromatographic studies with immobilized neuronal nicotinic acetylcholine receptor stationary phases: effects of receptor subtypes, pH and ionic strength on drug-receptor interactions. J. Chromatogr. B 1999, 724:65-72.
41. Moaddel R., Jozwiak K., Yamaguchi R., Cobello C., Whittington K., Sarkar T.K., Basak S., Wainer I.W. On-line screening of conformationally constrained nicotines and anabasines for agonist activity at the alpha3beta4- and alpha4beta2-nicotinic acetylcholine receptors using immobilized receptor-based liquid chromatographic stationary phases. J. Chromatogr. B 2004, 813:235-240.
42. Moaddel R., Oliveira R.V., Kimura T., Hyppolite P., Juhaszova M., Xiao Y., Kellar K.J., Bernier M., Wainer I.W. Initial synthesis and characterization of an alpha7 nicotinic receptor cellular membrane affinity chromatography column: effect of receptor subtype and cell type. Anal. Chem. 2008, 80:48-54.
43. Moaddel R., Cloix J.-F., Ertem G., Wainer I.W. Multiple receptor liquid chromatographic stationary phases: the co-immobilization of nicotinic receptors, the g-amino-butyric acid receptors, the N-methyl d-aspartate receptors. Pharm. Res. 2002, 19:104-107.
44. Kitabatake T., Moaddel R., Cole R., Gandhari M., Frazier C., Hartenstein J., Rosenberg A., Bernier M., Wainer I.W. Characterization of a multiple ligand-gated ion channel cellular membrane affinity chromatography column and identification of endogenously expressed receptors in astrocytoma cell lines. Anal. Chem. 2008, 80:8673-8680.
45. Du H., He J., Wang S., He L. Investigation of calcium antagonist-L-type calcium channel interactions by a vascular smooth muscle cell membrane chromatography method. Anal. Bioanal. Chem. 2010, 397:1947-1953.
46. Heilker R., Wolff M., Tautermann C.S., Bieler M. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov. Today 2009, 14:231-240.
47. Beigi F., Chakir K., Xiao R.-P., Wainer I.W. G-protein-coupled receptor chromatographic stationary phases. 2. Ligand-induced conformational mobility in an immobilized β2-adrenergic receptor. Anal. Chem. 2004, 76:7187-7193.
48. Moaddel R., Calleri E., Massolini G., Frazier C.R., Wainer I.W. The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening. Anal. Biochem. 2007, 364:216-218.
49. Moaddel R., Musyimi H.K., Sanghvi M., Bashore C., Frazier C.R., Khadeer M., Bhatia P., Wainer I.W. Synthesis and characterization of a cellular membrane affinity chromatography column containing histamine 1 and P2Y1 receptors: a multiple G-protein coupled receptor column. J. Pharm. Biomed. Anal. 2010, 52:416-419.
50. Temporini C., Ceruti S., Calleri E., Ferrario S., Moaddel R., Abbracchio M.P., Massolini G. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry. Anal. Biochem. 2009, 384:123-129.
51. Calleri E., Ceruti S., Cristalli G., Martini C., Temporini C., Parravicini C., Volpini R., Daniele S., Caccialanza G., Lecca D., Lambertucci C., Trincavelli M.L., Marucci G., Wainer I.W., Ranghino G., Fantucci P., Abbracchio M.P., Massolini G. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. J. Med. Chem. 2010, 53:3489-3501.
52. Beigi F., Wainer I.W. Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors. Anal. Chem. 2003, 75:4480-4485.
53. Toledo-Sherman L., Deretey E., Slon-Usakiewicz J.J., Ng W., Dai J.R., Foster J.E., Redden P.R., Uger M.D., Liao L.C., Pasternak A., Reid N. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening. J. Med. Chem. 2005, 48:3221-3230.
54. Slon-Usakiewicz J.J., Dai J.R., Ng W., Foster J.E., Deretey E., Toledo-Sherman L., Redden P.R., Pasternak A., Reid N. Global kinase screening. Applications of frontal affinity chromatography coupled to mass spectrometry in drug discovery. Anal. Chem. 2005, 77:1268-1274.
55. Moore J.T., Collins J.L., Pearce K.H. The nuclear receptor superfamily and drug discovery. ChemMedChem 2006, 1:504-523.
56. Fechner P., Gauglitz G., Gustafsson J.-A. Neclear receptors in analytics-a fruitful joint venture or wasteful futility?. Trends Anal. Chem. 2010, 4:297-305.
57. Sanghvi M., Moaddel R., Frazier C., Wainer I.W. Synthesis and characterization of liquid chromatographic columns containing the immobilized ligand binding domain of the estrogen related receptor alpha and estrogen related receptor gamma. J. Pharm. Biomed. Anal. 2010, 53:777-780.
58. Chan N.W., Lewis D.F., Rosner P.J., Kelly M.A., Schriemer D.C. Frontal affinity chromatography-mass spectrometry assay technology for multiple stages of drug discovery: applications of a chromatographic biosensor. Anal. Biochem. 2003, 319:1-12.